{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:30:36Z","timestamp":1786411836564,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017784","name":"Gilead Research Scholars Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004965","name":"Sixth Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004965","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.isci.2025.111942","type":"journal-article","created":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T02:37:35Z","timestamp":1738377455000},"page":"111942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global functional genomics reveals GRK5 as a cystic fibrosis therapeutic target synergistic with current modulators"],"prefix":"10.1016","volume":"28","author":[{"given":"Hugo M.","family":"Botelho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miqu\u00e9ias","family":"Lopes-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madalena C.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violeta","family":"Railean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Pankonien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana F.","family":"Caleiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luka A.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco","family":"Cachatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Moiteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiraporn","family":"Ousingsawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kunzelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Pepperkok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida D.","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.111942_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.111942_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-0636","article-title":"Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation patient registry","volume":"161","author":"MacKenzie","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.isci.2025.111942_bib3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.isci.2025.111942_bib4","unstructured":"Rommens, J.M. (2022). Cystic Fibrosis Mutation Database. http:\/\/www.genet.sickkids.on.ca\/cftr\/."},{"key":"10.1016\/j.isci.2025.111942_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/JMN:23:1-2:041","article-title":"CFTR and chaperones: processing and degradation","volume":"23","author":"Amaral","year":"2004","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.isci.2025.111942_bib6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/354526a0","article-title":"Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation","volume":"354","author":"Dalemans","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111942_bib7","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1021\/cb300484r","article-title":"HGF stimulation of Rac1 signaling enhances pharmacological correction of the most prevalent cystic fibrosis mutant F508del-CFTR","volume":"8","author":"Moniz","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib8","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores DeltaF508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/358761a0","article-title":"Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive","volume":"358","author":"Denning","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111942_bib10","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111942_bib11","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111942_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1096\/fj.12-216119","article-title":"Correctors of DeltaF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein","volume":"27","author":"He","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.isci.2025.111942_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","article-title":"Mechanism of CFTR correction by type I folding correctors","volume":"185","author":"Fiedorczuk","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111942_bib14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.chembiol.2013.06.004","article-title":"Revertants, Low Temperature, and Correctors Reveal the Mechanism of F508del-CFTR Rescue by VX-809 and Suggest Multiple Agents for Full Correction","volume":"20","author":"Farinha","year":"2013","journal-title":"Chem. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib15","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1007\/s00018-021-03994-5","article-title":"Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR","volume":"78","author":"Baatallah","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.111942_bib16","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1128\/MCB.25.12.5242-5252.2005","article-title":"Most F508del-CFTR is targeted to degradation at an early folding checkpoint and independently of calnexin","volume":"25","author":"Farinha","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.isci.2025.111942_bib17","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.2174\/13816128113199990318","article-title":"Rescuing mutant CFTR: a multi-task approach to a better outcome in treating cystic fibrosis","volume":"19","author":"Amaral","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.isci.2025.111942_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112989","article-title":"How to determine the mechanism of action of CFTR modulator compounds: A gateway to theranostics","volume":"210","author":"Amaral","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib19","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.043448","article-title":"Membrane trafficking in health and disease","volume":"13","author":"Yarwood","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.isci.2025.111942_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-016-2387-7","article-title":"From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking","volume":"74","author":"Farinha","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.111942_bib21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cell.2006.06.041","article-title":"Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator","volume":"126","author":"Younger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111942_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1126\/science.277.5325.556","article-title":"A di-acidic signal required for selective export from the endoplasmic reticulum","volume":"277","author":"Nishimura","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.isci.2025.111942_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1083\/jcb.200401035","article-title":"COPII-dependent export of cystic fibrosis transmembrane conductance regulator from the ER uses a di-acidic exit code","volume":"167","author":"Wang","year":"2004","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.isci.2025.111942_bib24","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0092-8674(93)90233-G","article-title":"Identification of revertants for the cystic fibrosis delta F508 mutation using STE6-CFTR chimeras in yeast","volume":"73","author":"Teem","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111942_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00197165","article-title":"Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene","volume":"87","author":"D\u00f6rk","year":"1991","journal-title":"Hum. Genet."},{"key":"10.1016\/j.isci.2025.111942_bib26","doi-asserted-by":"crossref","first-page":"9038","DOI":"10.1038\/srep09038","article-title":"Protein traffic disorders: an effective high-throughput fluorescence microscopy pipeline for drug discovery","volume":"5","author":"Botelho","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.111942_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4939-3804-9_7","article-title":"Investigating Alternative Transport of Integral Plasma Membrane Proteins from the ER to the Golgi: Lessons from the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)","volume":"1459","author":"Amaral","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature15729","article-title":"\u0394F508 CFTR interactome remodelling promotes rescue of cystic fibrosis","volume":"528","author":"Pankow","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111942_bib29","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1007\/s00018-018-2896-7","article-title":"Proteomic interaction profiling reveals KIFC1 as a factor involved in early targeting of F508del-CFTR to degradation","volume":"75","author":"Canato","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.isci.2025.111942_bib30","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1038\/s41598-017-06588-z","article-title":"Targeting the PI3K\/Akt\/mTOR signalling pathway in Cystic Fibrosis","volume":"7","author":"Reilly","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.111942_bib31","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1074\/jbc.M117.816595","article-title":"High-throughput screening identifies FAU protein as a regulator of mutant cystic fibrosis transmembrane conductance regulator channel","volume":"293","author":"Tomati","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239189","article-title":"Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation","volume":"15","author":"Dang","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.111942_bib33","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cell.2013.08.045","article-title":"High-content siRNA screen reveals global ENaC regulators and potential cystic fibrosis therapy targets","volume":"154","author":"Alma\u00e7a","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111942_bib34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncb2510","article-title":"Genome-wide RNAi screening identifies human proteins with a regulatory function in the early secretory pathway","volume":"14","author":"Simpson","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2025.111942_bib35","doi-asserted-by":"crossref","DOI":"10.15252\/msb.202110629","article-title":"CFTR interactome mapping using the mammalian membrane two-hybrid high-throughput screening system","volume":"18","author":"Lim","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10910-0","article-title":"Epithelial Chloride Transport by CFTR Requires TMEM16A","volume":"7","author":"Benedetto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.111942_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cellsig.2018.01.008","article-title":"Compartmentalized crosstalk of CFTR and TMEM16A (ANO1) through EPAC1 and ADCY1","volume":"44","author":"Lerias","year":"2018","journal-title":"Cell. Signal."},{"key":"10.1016\/j.isci.2025.111942_bib38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbamcr.2017.11.009","article-title":"A novel microscopy-based assay identifies extended synaptotagmin-1 (ESYT1) as a positive regulator of anoctamin 1 traffic","volume":"1865","author":"L\u00e9rias","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.isci.2025.111942_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167436","article-title":"Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic Fibrosis","volume":"434","author":"Pinto","year":"2022","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib40","doi-asserted-by":"crossref","first-page":"35825","DOI":"10.1074\/jbc.M110.131623","article-title":"The cystic fibrosis-causing mutation deltaF508 affects multiple steps in cystic fibrosis transmembrane conductance regulator biogenesis","volume":"285","author":"Thibodeau","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib41","doi-asserted-by":"crossref","first-page":"17891","DOI":"10.1073\/pnas.0608312103","article-title":"Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms","volume":"103","author":"Roxo-Rosa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.111942_bib42","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s41569-019-0220-3","article-title":"G protein-coupled receptor kinases as therapeutic targets in the heart","volume":"16","author":"Pfleger","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.isci.2025.111942_bib43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1073\/pnas.0135434100","article-title":"A macromolecular complex of beta 2 adrenergic receptor, CFTR, and ezrin\/radixin\/moesin-binding phosphoprotein 50 is regulated by PKA","volume":"100","author":"Naren","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.111942_bib44","doi-asserted-by":"crossref","first-page":"13796","DOI":"10.1074\/jbc.271.23.13796","article-title":"Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor","volume":"271","author":"Fredericks","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1021\/acs.jmedchem.0c01522","article-title":"Generation of Highly Selective, Potent, and Covalent G Protein-Coupled Receptor Kinase 5 Inhibitors","volume":"64","author":"Rowlands","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib46","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1042\/BJ20080029","article-title":"Evidence for direct CFTR inhibition by CFTRinh-172 based on Arg347 mutagenesis","volume":"413","author":"Caci","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2025.111942_bib47","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1038\/s41467-024-50641-1","article-title":"Allosteric inhibition of CFTR gating by CFTRinh-172 binding in the pore","volume":"15","author":"Gao","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111942_bib48","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2316675121","article-title":"Structural basis for CFTR inhibition by CFTRinh-172","volume":"121","author":"Young","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.111942_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ebiom.2014.12.005","article-title":"Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis","volume":"2","author":"Awatade","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2025.111942_bib49","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nature08869","article-title":"Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes","volume":"464","author":"Neumann","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111942_bib50","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/14728222.2018.1501361","article-title":"The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease","volume":"22","author":"Moore","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.isci.2025.111942_bib51","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.coph.2018.09.007","article-title":"The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis","volume":"43","author":"Shei","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.isci.2025.111942_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115931","article-title":"Development of a new class of potent and highly selective G protein-coupled receptor kinase 5 inhibitors and structural insight from crystal structures of inhibitor complexes","volume":"264","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008680","article-title":"Potentiator ivacaftor abrogates pharmacological correction of DeltaF508 CFTR in cystic fibrosis","volume":"6","author":"Cholon","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.111942_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008889","article-title":"Some gating potentiators, including VX-770, diminish \u0394F508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2025.111942_bib55","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111942_bib56","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.yjmcc.2016.01.027","article-title":"Canonical and non-canonical actions of GRK5 in the heart","volume":"92","author":"Traynham","year":"2016","journal-title":"J.\u00a0Mol. Cell. Cardiol."},{"key":"10.1016\/j.isci.2025.111942_bib57","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/cvr\/cvz188","article-title":"Epac1 inhibition as a novel cardioprotective strategy: lights and shadows on GRK5 canonical and non-canonical functions","volume":"115","author":"Boccella","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.isci.2025.111942_bib58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/164_2016_64","article-title":"\u03b2(2) Agonists","volume":"237","author":"Billington","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.isci.2025.111942_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/38514","article-title":"Stimulation of CFTR activity by its phosphorylated R domain","volume":"389","author":"Winter","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111942_bib60","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1242\/jcs.185629","article-title":"EPAC1 activation by cAMP stabilizes CFTR at the membrane by promoting its interaction with NHERF1","volume":"129","author":"Lobo","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.isci.2025.111942_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2011.08.001","article-title":"G protein-coupled receptor kinases: more than just kinases and not only for GPCRs","volume":"133","author":"Gurevich","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.isci.2025.111942_bib62","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1016\/S0021-9258(18)89201-8","article-title":"Homologous desensitization of adenylate cyclase is associated with phosphorylation of the beta-adrenergic receptor","volume":"260","author":"Sibley","year":"1985","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2025.111942_bib63","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1021\/bi00392a042","article-title":"Catecholamine-induced desensitization of adenylate cyclase coupled beta-adrenergic receptors in turkey erythrocytes: evidence for a two-step mechanism","volume":"26","author":"Stadel","year":"1987","journal-title":"Biochemistry"},{"key":"10.1016\/j.isci.2025.111942_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14728222.2019.1575363","article-title":"GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy","volume":"23","author":"Lieu","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.isci.2025.111942_bib65","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3389\/fphar.2018.01484","article-title":"GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders","volume":"9","author":"Hendrickx","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2025.111942_bib66","doi-asserted-by":"crossref","first-page":"15895","DOI":"10.1073\/pnas.1818547116","article-title":"Perturbation of the interactions of calmodulin with GRK5 using a natural product chemical probe","volume":"116","author":"Beyett","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.111942_bib74","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2006-7-10-r100","article-title":"CellProfiler: image analysis software for identifying and quantifying cell phenotypes","volume":"7","author":"Carpenter","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2025.111942_bib68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-61779-120-8_15","article-title":"Functional genomics assays to study CFTR traffic and ENaC function","volume":"742","author":"Alma\u00e7a","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib69","doi-asserted-by":"crossref","first-page":"C872","DOI":"10.1152\/ajpcell.00507.2010","article-title":"Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling","volume":"301","author":"Sondo","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.isci.2025.111942_bib70","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1113\/jphysiol.2005.096669","article-title":"Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers","volume":"569","author":"Bebok","year":"2005","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.isci.2025.111942_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-61779-117-8_2","article-title":"High-throughput screening of libraries of compounds to identify CFTR modulators","volume":"741","author":"Pedemonte","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.isci.2025.111942_bib72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nprot.2006.483","article-title":"Reverse transfection on cell arrays for high content screening microscopy","volume":"2","author":"Erfle","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2025.111942_bib73","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.1093\/bioinformatics\/btaa1073","article-title":"An open-source high-content analysis workflow for CFTR function measurements using the forskolin-induced swelling assay","volume":"36","author":"Hagemeijer","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.111942_bib75","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00373009","article-title":"Simultaneous recording of the cell membrane potential and properties of the cell attached membrane of HT29 colon carcinoma and CF-PAC cells","volume":"419","author":"Greger","year":"1991","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.isci.2025.111942_bib76","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/bioinformatics\/btx657","article-title":"heatmaply: an R package for creating interactive cluster heatmaps for online publishing","volume":"34","author":"Galili","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2025.111942_bib77","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1101\/gr.772403","article-title":"PANTHER: a library of protein families and subfamilies indexed by function","volume":"13","author":"Thomas","year":"2003","journal-title":"Genome Res."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225002020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225002020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:15:46Z","timestamp":1786410946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225002020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2589004225002020"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.111942","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global functional genomics reveals GRK5 as a cystic fibrosis therapeutic target synergistic with current modulators","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.111942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111942"}}